2016年6月24-25日，临床肿瘤学新进展学术研讨会——Best of ASCO Event in China2016在杭州召开。24日下午的乳腺癌专场上，江苏省人民医院、中国抗癌协会乳腺癌专业委员会委员殷咏梅带来了三项乳腺癌的重要研究报告。

三项研究摘要编号和题目：

Abstract 512

Efficacy of palbociclib plusfulvestrant (P+F) in patients (pts) with metastatic breast cancer (MBC) andESR1 mutations (mus) in circulating tumor DNA (ctDNA).

Abstract 507

PALOMA-2: Primary results froma phase 3 trial of palbociclib (P) with letrozole (L) compared with letrozolealone in postmenopausal women with ER+/HER2– advancedbreast cancer (ABC).

Abstract 500

Pathologic complete responserates after neoadjuvant trastuzumab emtansine (T-DM1) + pertuzumab vs docetaxel+ carboplatin +trastuzumab + pertuzumab treatment in patients withHER2-positive early breast cancer (KRISTINE).

直通车：刘健教授对乳腺癌三个重要研究进行评述

会议专题》》》2016临床肿瘤学新进展学术研讨会（BOA）